At a glance: Zinc's established nutritional functions do not prove the suitability or effectiveness of every colloidal dispersion. The material in a study must be identified before its findings can be applied to a product.
Zinc as a nutrient
Zinc is needed for many enzymes and proteins. An adequate supply contributes to normal immune function and maintenance of normal skin, hair and nails.
In the EU, authorised nutrient claims have specified conditions of use. These functions do not establish an extra benefit above nutritional needs or show that every zinc form is equivalent. A product still needs an appropriate composition and lawful intended use.
What a colloidal liquid may contain
The term does not identify a uniform preparation. A liquid may contain particles, dissolved zinc ions, zinc oxide particles, stabilisers or mixtures. These components can behave differently.
A study using characterised zinc oxide nanoparticles is not automatically a study of a retail zinc dispersion. Sharing the element's name is not enough to connect the two.
Particles and ions in biological environments
Dissolved ions and solid particles differ in availability and behaviour. Particle size, shape, surface chemistry, charge and aggregation can influence interactions with cells and surrounding fluids.
Properties may change in biological media. A result depends on the material, the amount, the exposure route and the experimental conditions. A positive cell-culture finding cannot by itself demonstrate a health benefit in people.
What useful product data would include
- Chemical identity and relevant forms present.
- Particle-size distribution and measurement methods.
- Total zinc and the dissolved fraction.
- Purity, stability and traceability.
- A clearly stated intended use and relevant safety evidence.
A PPM figure is only a proportion with a stated basis. It does not provide the complete specification or show how much elemental zinc a person would receive from a stated portion.
Safety and total intake
For a supplement, the permitted nutrient source, labelling and total zinc intake from food and other products matter. Excessive long-term zinc intake can interfere with copper absorption, and interactions with certain medicines are possible.
EFSA's guidance on nanomaterial risk assessment explains why material properties and exposure require specific attention. A guidance document is not an approval of an individual product.
Practical conclusion
Research on zinc is broad, but its findings remain tied to defined materials and questions. Compare the study preparation with the actual product and distinguish normal nutrient functions from claims to treat a disease.
Frequently asked questions
Does a cell study of zinc oxide nanoparticles apply to every zinc liquid?
No. The compound, particle properties, amount and experimental system can differ substantially. The particular product needs relevant evidence.
Is EFSA nanomaterial guidance a product approval?
No. It describes assessment requirements. It does not give an individual product general approval or establish its effectiveness.
Related guides
- Colloidal zinc for a cold? Why the formulation matters
- Colloidal zinc for skin, hair and nails: nutrition versus treatment claims
- What are colloids? Dispersions, particles and solutions explained
Sources and further reading
- NIH Office of Dietary Supplements: Zinc
- EUR-Lex: Regulation 432/2012 on authorised health claims
- EFSA (2021): guidance on risk assessment of nanomaterials in the food and feed chain
Editorial update: 4 October 2026. General information; not an individual diagnosis, treatment, ingestion or dosage recommendation.